Outpatient genetic testing revealed heterozygosity for a variant of unknown significance in the cardiac ryanodine receptor (RYR2), a gene where pathogenic variants have been linked to CPVT. This evidence concerns the gene RYR2 and catecholaminergic polymorphic ventricular tachycardia.